Basic information Safety Supplier Related

ETHYL 4,4-DIFLUOROCYCLOHEXANECARBOXYLATE

Basic information Safety Supplier Related

ETHYL 4,4-DIFLUOROCYCLOHEXANECARBOXYLATE Basic information

Product Name:
ETHYL 4,4-DIFLUOROCYCLOHEXANECARBOXYLATE
Synonyms:
  • 4,4-Difluoro-1-(ethoxycarbonyl)cyclohexane
  • Ethyl 4,4-difluorocyclohexane-1-carboxylate
  • ETHYL 4,4-DIFLUOROCYCLOHEXANECARBOXYLATE
  • Ethyl 4,4-difluorocyclohexanedicarboxylate
  • Cyclohexanecarboxylic acid, 4,4-difluoro-, ethyl ester (9CI)
  • Cyclohexanecarboxylic acid, 4,4-difluoro-, ethyl ester
  • Ethyl 4,4-dilfuorocyclohexanecarboxylate
  • 1-ethyl-4,4-difluoro-1-cyclohexanecarboxylate
CAS:
178312-47-5
MF:
C9H14F2O2
MW:
192.2
EINECS:
674-534-3
Product Categories:
  • Esters
  • Ring Systems
  • CARBOXYLICESTER
  • Drug Intermediates
Mol File:
178312-47-5.mol
More
Less

ETHYL 4,4-DIFLUOROCYCLOHEXANECARBOXYLATE Chemical Properties

Boiling point:
84-86°C/8mm
Density 
1.10±0.1 g/cm3(Predicted)
Flash point:
84-86°C/8mm
storage temp. 
2-8°C
form 
solid
color 
Yellow
InChI
InChI=1S/C9H14F2O2/c1-2-13-8(12)7-3-5-9(10,11)6-4-7/h7H,2-6H2,1H3
InChIKey
HZZDWLBBNSDYQM-UHFFFAOYSA-N
SMILES
C1(C(OCC)=O)CCC(F)(F)CC1
CAS DataBase Reference
178312-47-5(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
Xi
Safety Statements 
24/25
HazardClass 
IRRITANT
HS Code 
2916200090
More
Less

ETHYL 4,4-DIFLUOROCYCLOHEXANECARBOXYLATE Usage And Synthesis

Uses

4,4-Difluorocyclohexanecarboxylic Acid Ethyl Ester is used as a reactant in the preparation of antiretroviral drug Maraviroc (M193000), which is CCR-5 receptor antagonist used for the treatment of HIV.

Synthesis

17159-79-4

178312-47-5

General procedure for the synthesis of ethyl 4,4-difluorocyclohexanecarboxylate from ethyl cyclohexanonecarboxylate: ethyl 4-oxocyclohexanecarboxylate (5 g, 29 mmol) of the compound 4-oxocyclohexanecarboxylic acid (5 g, 29 mmol) was slowly added dropwise by dissolving DAST (7.7 mL) in 75 mL CCl4 at 0 °C. After the dropwise addition was completed, the reaction mixture was stirred at room temperature for 16 hours. Upon completion of the reaction, the reaction was quenched by slow addition of water, the organic phase was separated, washed with water and dried with Na2SO4. Finally, purification by distillation gave ethyl 4,4-difluorocyclohexanecarboxylate as a colorless oil (4.2 g, 71% yield).

References

[1] Patent: WO2013/13188, 2013, A1. Location in patent: Paragraph 00312
[2] Patent: US9416132, 2016, B2. Location in patent: Page/Page column 134
[3] Patent: US2014/275080, 2014, A1. Location in patent: Paragraph 0427
[4] Patent: WO2018/213150, 2018, A1. Location in patent: Page/Page column 20; 21; 28
[5] Patent: US5968923, 1999, A

ETHYL 4,4-DIFLUOROCYCLOHEXANECARBOXYLATESupplier

BTC Pharmaceutical CO. Ltd Gold
Tel
15716293042 18862996710
Email
15050603958@163.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Alfa Aesar
Tel
400-6106006
Email
saleschina@alfa-asia.com
Ark Pharm, Inc.
Tel
847-367-3680
Email
sales@arkpharminc.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com